Fig. 2
From: Serum levels of S100A6 are unaltered in patients with resectable cholangiocarcinoma
Analysis of S100A6 levels is not suitable for diagnosis of CCA. a S100A6 levels measured by commercially available ELISA at the time point of admission to our hospital were unaltered in patients with CCA (n = 112) compared to healthy controls (n = 42). b No significant alterations were observed between intra-hepatic CCA, Klatskin tumors, distal CCA and gallbladder cancer. c Patients with a CCA due to a PSC displayed significantly higher serum concentrations than other patients. No alterations in S100A6 serum levels were found for HCC patients